EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.2.2.5 | additional information | all the amino-acids tested Asp, Arg, Cys, His, Gln, Thr, Glu and Ser, are unable to produce enhancement of hydrolysis | Helicobacter pylori |
EC Number | Application | Comment | Organism |
---|---|---|---|
3.2.2.5 | medicine | vaccination with CagL has protective efficacy in mice | Helicobacter pylori |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.2.2.5 | Helicobacter pylori | - |
- |
- |
3.2.2.5 | Helicobacter pylori Shi470 | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.2.2.5 | NAD+ + H2O | - |
Helicobacter pylori | ADP-D-ribose + nicotinamide | - |
? | |
3.2.2.5 | NAD+ + H2O | - |
Helicobacter pylori Shi470 | ADP-D-ribose + nicotinamide | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.2.2.5 | CagL | - |
Helicobacter pylori |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.2.2.5 | physiological function | CagL from Shi470 is catalytically active showing ADP-ribosyltransferase, NAD-glycohydrolase, and auto-ADP-ribosylation activities | Helicobacter pylori |